Previous 10 | Next 10 |
home / stock / tkphf / tkphf news
Quick Take Nkarta ( NKTX ) intends to raise $150 million in an IPO of its common stock, according to an amended registration statement . The company is advancing a pipeline of drug candidates for the treatment of blood and other cancer indications. NKTX is still at preclinical stage of ...
Takeda Reports Positive Data for Late Stage Multiple Myeloma Trial Takeda Pharmaceutical Company Limited (TAK) announced data from its Phase 3 clinical trial of single-agent oral NINLARO as well as from the US MM-6 study. NINLARO, in combination with lenalidomide and dexamethasone, is curr...
The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with this Read more ...
There are many levels to the coronavirus pandemic and a massive effort is underway to find a vaccine and treatments. Genetic Engineering News summarised 161+ candidates. The US clinical trials website indicates 1,915 trials underway using the keyword COVID-19 (June 3, 2020). The common c...
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 05/15/2020. Please visit our Tracking Larry Robbins’ Glenview Capital Manage...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking John Paulson’s Paulson & Co...
Takeda Receives FDA Approval for Brigatinib Takeda Pharmaceutical Company Limited ( TAK ) announced that the FDA has given a green signal for its ALUNBRIG (Brigatinib) in adult patients suffering from anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer. The lab...
Takeda Pharmaceutical Company Limited (TKPHF) Q4 2019 Earnings Conference Call May 13, 2020, 08:30 AM ET Company Participants Takashi Okubo - IR Christophe Weber - President and CEO Andrew Plump - President of R&D Costa Saroukos - CFO Ramona Sequeira - President of USBU a...
The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with their 2019 Q4 earnings Read more ...
Quick Take ADC Therapeutics ( ADCT ) intends to raise $125 million from the sale of its common stock, per an amended registration statement . The company is advancing a pipeline of drug candidates for the treatment of blood cancers and solid tumors. ADCT is making a new attempt to go pu...
News, Short Squeeze, Breakout and More Instantly...
Takeda Pharmaceutical Co Ltd Company Name:
TKPHF Stock Symbol:
OTCMKTS Market:
Takeda Pharmaceutical Co Ltd Website:
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...
Verbund AG ADR (OEZVY) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-6.56 for Q1 2025 Johnson Matthey plc ADR (JMPLY) is expected to report for Q4 2024 RVL Pharmaceuticals plc (RVLPQ) is expected to report for Q1 2024 Ciena Corporation (CIEN...
JD.com Inc. (JD) is expected to report $0.56 for Q1 2024 Volkswagen AG (VLKAF) is expected to report for Q1 2024 CalAmp Corp. (CAMP) is expected to report for Q4 2024 Sonic Foundry Inc. (SOFO) is expected to report for Q2 2024 Moatable Inc ADR (R2RS:MU) is expected to report for Q...